which glp 1 is best for cardiovascular benefit Could GLP-1 medications be helpful your heart? Our experts weigh in on the potential benefits and side effects of the popular weight loss medications Glucagon-like peptide 1 receptor agonists:

TZP is a new pharmacological approach which includes dual agonism, approved in May 2022 by the United States Food and Drug Administration (FDA) for the treatment of T2D and in November 2023 for the treatment of obesity (37)

Eligibility is determined by standard clinical criteria rather than genetic predisposition

The mechanisms of these drugs, which include slowing gastric emptying and signaling fullness to the brain, work synergistically with a high-protein diet to enhance these effects

10.2337/diacare.12.8.553 9 BaileyC

Your provider will align the route, dose, and monitoring with your goals and health history and adjust based on how you respond